For the Total difficulties score, the phone survey was associated with a smaller chance of borderline classification (OR = 0.63).
Scoring was performed by at least two investigators (in very few borderline cases, classification of immunostaining required additional investigators and was based on the consistency of the majority of them).
For the purposes of this study, the two deviant classifications (borderline and clinical) were grouped together and further relabeled as "at risk of" (cutoff criteria for each scale/subscale are presented in Table 2).
The data shows that the mean scores on both SDQ scales are within the ranges considered by Mellor [ 26] to be "normal" (see http://www.sdqinfo.org), nevertheless the scores for the Total Difficulties scale extended across the "normal", "borderline" and "abnormal" classifications, as defined in the scoring instructions.
Statistically significant differences in the probability of a borderline or abnormal classification for the phone survey were tested using multinomial logistic regression.
However, on POD 18, he developed elevated SCr and graft biopsy revealed acute T cell-mediated rejection (ATMR, Banff classification, borderline change).
According to the Ridley-Jopling classification, borderline lepromatous leprosy was diagnosed and the patient received rifampicin (600 mg/month), minocycline (100 mg/day) instead of dapsone because of anemia, and clofazimine (300 mg/month and 50 mg/day).
The results show that higher cord adducts were associated with increased likelihood of borderline or clinical classification on the DSM-oriented Anxiety Problem Scale (OR = 8.30, 95% CI, 1.13 60.71) at 4.8 years of age.
The results were significant for the syndromes of Attention Problems at 7 years [odds ratio (OR) = 3.30, 95% CI, 1.21 12.54] and Anxious/Depressed at 4.8 years (OR = 8.14, 95% CI, 1.21 54.94), showing that higher cord adducts were associated with increased likelihood of borderline or clinical classification on Anxious/Depressed and Attention Problems.
